文献速递艾滋病与性传播感染

阴茎免疫激活与HIV排毒风险:前瞻性队列研究

Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
PubMed 文献 · Clin Infect Dis · 2017-01-01

在乌干达拉凯对221名接受男性包皮环切术的HIV感染者进行前瞻性观察队列研究,分析包皮沟灌洗液中促炎细胞因子与HIV RNA。主要分析限于175名血浆VL>400 copies/mL的男性(808次访视)。结果显示促炎细胞因子检测与后续访视阴茎HIV排毒风险呈剂量依赖性和时间关联。

要点

  • 检测到IL-1β、IL-6、IL-8、IL-10、IL-13与后续阴茎HIV排毒风险增加相关。
  • 检测到2-4种或5-7种细胞因子者后续排毒风险高于≤1种者,呈剂量依赖。
  • 细胞因子总数还与排毒者后续阴茎HIV log10 VL较高相关。

核心结论

  • 促炎细胞因子产生与阴茎HIV排毒存在剂量依赖性和时间关联,提示生殖道免疫激活可能通过驱动局部HIV复制增加性传播风险。

研究设计与样本

  • 前瞻性观察队列研究,在乌干达拉凯纳入221名接受男性包皮环切术的HIV感染者。
  • 主要分析限于175名血浆VL>400 copies/mL的男性,共808次访视。
  • 基线和术后4次每周访视采集包皮沟灌洗液,检测促炎细胞因子和HIV RNA。

主要发现

  • 血浆VL可检测的男性中,136次访视(16.8%)检测到阴茎HIV排毒。
  • 检测到IL-1β(adjPRR=2.14;95%CI=1.02-4.48)与后续阴茎HIV排毒相关。
  • 检测到IL-6(adjPRR=2.24;95%CI=1.28-3.90)与后续阴茎HIV排毒相关。
  • 检测到IL-8(adjPRR=2.42;95%CI=1.15-5.08)与后续阴茎HIV排毒相关。
  • 检测到IL-10(adjPRR=2.51;95%CI=1.67-3.80)和IL-13(adjPRR=1.87;95%CI=1.15-3.03)与后续阴茎HIV排毒相关。

关键数值与推荐

  • 阴茎HIV排毒定义为灌洗液HIV VL>40 copies/mL。
  • 血浆VL可检测定义为>400 copies/mL。
  • 与≤1种可检测细胞因子相比,2-4种者adjPRR=2.36(95%CI=1.08-5.14),5-7种者adjPRR=3.00(95%CI=1.28-7.01)。

临床怎么用

  • 对于血浆VL可检测的HIV感染者,生殖道促炎细胞因子检测可能有助于识别阴茎HIV排毒风险较高者。
  • 临床可关注生殖道炎症控制,以可能降低局部HIV排毒和性传播风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Genital immune activation is suspected to modulate local human immunodeficiency virus (HIV) RNA levels and the risk of sexual HIV transmission. METHODS: A prospective, observational cohort study of 221 HIV-infected men undergoing male circumcision (MC) was conducted in Rakai, Uganda. Penile lavage samples collected from the coronal sulcus at baseline and 4 weekly visits after MC were assayed for pro-inflammatory cytokines and HIV RNA. The main analysis was limited to 175 men with detectable HIV plasma viral load (VL > 400 copies/mL; n = 808 visits). The primary exposures of interest were individual and total cytokine detection at the previous postoperative visit. Adjusted prevalence risk ratios (adjPRR) of detectable HIV shedding (VL > 40 copies/mL) were estimated by Poisson regression models with generalized estimating equations and robust variance estimators and included adjustment for plasma HIV VL. FINDINGS: Among men with a detectable plasma VL, penile HIV shedding was detected at 136 visits (16.8%). Detectable interleukin (IL)-1β (adjPRR = 2.14; 95% confidence interval (CI) = 1.02-4.48), IL-6 (adjPRR = 2.24; 95% CI = 1.28-3.90), IL-8 (adjPRR = 2.42; 95% CI = 1.15-5.08), IL-10 (adjPRR = 2.51; 95% CI = 1.67-3.80), and IL-13 (adjPRR = 1.87; 95% CI = 1.15-3.03) were associated with penile HIV shedding at the subsequent visit. Men with 2-4 (adjPRR = 2.36; 95% CI = 1.08-5.14) and 5-7 (adjPRR = 3.00; 95% CI = 1.28-7.01) detectable cytokines had a greater likelihood of detectable penile HIV shedding at the subsequent visit, compared to men with ≤ 1 detectable cytokine. The total number of detectable cytokines was also associated with a higher penile log10 HIV VL at the subsequent visit among HIV shedders. INTERPRETATION: Pro-inflammatory cytokine production had a dose-dependent and temporal association with penile HIV shedding, suggesting that genital immune activation may increase the risk of sexual HIV transmission by driving local HIV replication.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Patel EU, Kirkpatrick AR, Grabowski MK, et al. Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study. Clin Infect Dis. 2017. PMID: 28011606. doi:10.1093/cid/ciw847

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。